SARAH HILLIER: Open Payments
NPI 1568894830 · GLOUCESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 50 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,333 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $149 |
| Novartis Pharmaceuticals Corporation | 7 | $147 |
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| ABBVIE INC. | 6 | $112 |
| UCB, Inc. | 3 | $85 |
| Janssen Biotech, Inc. | 4 | $69 |
| Incyte Corporation | 3 | $60 |
| GENZYME CORPORATION | 2 | $52 |
| Galderma Laboratories, L.P. | 3 | $47 |
| Lilly USA, LLC | 3 | $47 |
Products named: DUPIXENT, OTEZLA, COSENTYX, Bimzelx, SKYRIZI, TREMFYA, OPZELURA, NEMLUVIO.
Industry payments across VA — which companies pay providers there.
